Serotonin in Medical Technology
Navigation Links
Serotonin in Medical Technology
Lexicon's Drug Candidate LX1032 for Carcinoid Syndrome Receives Orphan Drug Designation From EMEA
... syndrome . LX1032 is designed to reduce serotonin production in patients with metastatic carcinoid tumors. Elevated levels of serotonin contribute to the gastrointestinal and possibly ... was discovered and developed at Lexicon to reduce serotonin production by inhibiting tryptophan hydroxylase ...... The development of a potentially life-threatening serotonin syndrome may occur with use of SNRI products, ... and with drugs which impair metabolism of serotonin (including MAOIs). serotonin syndrome may include mental-status changes (e.g., ...
... into its Phase 2b study of Bicifadine -- a serotonin and norepinephrine reuptake inhibitor (SNRI) -- ... has a unique ratio of reuptake inhibition of serotonin versus norepinephrine, which differentiates it ... pain and HCV. XTL is developing Bicifadine, a serotonin and norepinephrine reuptake inhibitor, for the ...
... were excluded from this study. About Cymbalta serotonin and norepinephrine in the brain and spinal cord ... is a balanced and potent reuptake inhibitor of serotonin and norepinephrine that is believed to potentiate ... may be due to increasing the activity of serotonin and norepinephrine in the central nervous ...
... for an injury to heal.(ii) About Cymbalta serotonin and norepinephrine in the brain and spinal cord ... is a balanced and potent reuptake inhibitor of serotonin and norepinephrine that is believed to potentiate ... may be due to increasing the activity of serotonin and norepinephrine in the central nervous ...
... inverse agonist, or inhibitor, of the 5-HT2A serotonin receptor. serotonin activation of the 5-HT2A receptor on platelets ... cardiovascular tissues, APD791 may curb these serotonin mediated effects in the clinical setting, thereby ...
Five Clinical Studies to Receive $2.5 Million Under Foundation's 2007 Clinical Discovery Program
... Dr. Albin will investigate the role of serotonin neurons in PD-related sleep-disordered breathing. He will visualize serotonin neurons using an advanced medical imaging ... of Neuroscience in London hypothesizes that serotonin neurons are responsible for levodopa-induced ...FDA Approves Cymbalta(R) for Maintenance Treatment of Major Depressive Disorder
... Cymbalta since approval. About Cymbalta serotonin and norepinephrine in the brain and spinal cord ... is a balanced and potent reuptake inhibitor of serotonin and norepinephrine that is believed to potentiate ... may be due to increasing the activity of serotonin and norepinephrine in the central nervous ...... acid (5-HIAA), a metabolite of serotonin and biomarker for serotonin production, was observed in subjects who received ... studies demonstrated that LX1031 lowers serotonin levels in the intestine without affecting levels ...
New Data Suggest Cymbalta(R) Reduced Pain in Fibromyalgia Patients With and Without Depression
... debilitating condition." About Cymbalta serotonin and norepinephrine in the brain and spinal cord ... is a balanced and potent reuptake inhibitor of serotonin and norepinephrine that is believed to potentiate ... may be due to increasing the activity of serotonin and norepinephrine in the central nervous system. ...... a novel single agent that represents the first in a new class of selective serotonin 2C receptor agonists. The serotonin 2C receptor is located in areas of the brain involved in the control of ...
... a novel single agent that represents the first in a new class of selective serotonin 2C receptor agonists. The serotonin 2C receptor is located in areas of the brain involved in the control of ...
... addition of chromium histidinate to the diet significantly increased brain serotonin levels. Increased serotonin levels are known to improve mood and decrease carbohydrate cravings. ...
Key Protein May Lead to Faster Acting Anti-Depression Drugs
... vulnerability to depression. This new research shows that p11 activates a serotonin receptor in the brain known for producing rapid antidepressant response. ... Parkinson's Research Center scientists begun studying p11 because the serotonin system which is central to depression is connected to dopamine in ...... to date in healthy volunteers, indicated that the drug candidate reduced serotonin levels in humans as predicted by Lexicon's mouse models and preclinical ... including severe diarrhea and abdominal discomfort. LX1032 acts to reduce serotonin production by inhibiting tryptophan hydroxylase (TPH), a key enzyme in the ...
Cymbalta(R) Significantly Reduced Osteoarthritis Knee Pain in New Study
... and EuroQoL Questionnaire - 5 Dimension. About Cymbalta serotonin and norepinephrine in the brain and spinal cord are believed to both ... studies, Cymbalta is a balanced and potent reuptake inhibitor of serotonin and norepinephrine that is believed to potentiate the activity of these ...Lilly Withdraws Application for Additional U.S. Indication for Cymbalta(R) for Chronic Pain
... and unemployment.(v,vi,vii,viii) About Duloxetine serotonin and norepinephrine in the brain and spinal cord are believed to both ... studies, Duloxetine is a balanced and potent reuptake inhibitor of serotonin and norepinephrine that is believed to potentiate the activity of these ...FDA Approves Tapentadol Immediate-Release Tablets for Relief of Moderate to Severe Acute Pain
... of seizures. The development of a potentially life-threatening serotonin syndrome may occur with use of SNRI products, including tapentadol, ... SNRIs, TCAs, MAOIs and triptans, and with drugs which impair metabolism of serotonin (including MAOIs). The most common adverse events (greater than ...... oral and selective inverse agonist of the 5-HT2A serotonin receptor. serotonin activation of the 5-HT2A receptor on platelets and vascular smooth muscle ... to play an important role in events leading to thrombosis, and elevated serotonin levels have been associated with increased cardiovascular risk. Normally, ...
European CHMP Issues Positive Opinion on Cymbalta for the Treatment of Generalised Anxiety Disorder
... of action in humans is not fully known, it is believed to affect both serotonin and norepinephrine/noradrenaline mediated nerve signalling in the brain ... studies, duloxetine is a balanced and potent reuptake inhibitor of serotonin and norepinephrine/noradrenaline. Scientists believe its effect on pain ...Terguride Receives FDA Orphan Drug Designation for the Treatment of Pulmonary Arterial Hypertension
... can provide a significant therapeutic benefit in PAH by inhibiting excess serotonin signalling." The U.S. Orphan Drug Act is intended to assist and ... the blood vessels, which leads to PAH. Excessive proliferative effects of serotonin on the heart contribute directly to progression towards heart failure. ...Intra-Cellular Therapies Announces the Discovery of Potent Antidepressant Activity in ITI-007
... in vivo as an antidepressant. ITI-007 acts as a potent inhibitor of the serotonin transporter (SERT), a major target for most antidepressant drugs. To ... of bipolar disorders. ITI-007 also has nanomolar affinity for the serotonin transporter (SERT). ITI-007 has a much lower propensity than several ...... in vivo as an antidepressant. ITI-007 acts as a potent inhibitor of the serotonin transporter (SERT), a major target for most antidepressant drugs. To ... of bipolar disorders. ITI-007 also has nanomolar affinity for the serotonin transporter (SERT). ITI-007 has a much lower propensity than several ...
... seen with other antipsychotic therapies. Behaviorally, ITI-007 inhibited serotonin induced head twitches. Additionally, ITI-007 was shown to have an affinity for the serotonin reuptake site, an activity that potentially may be beneficial in treating ...
DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
... of antidepressant action, DOV 21,947 was more potent than Tofranil(R), a serotonin and norepinephrine reuptake inhibitor and the selective serotonin reuptake inhibitors Prozac(R) and Celexa(R). Because of its ability to ...Popular Breast Cancer Drug Used with Certain Antidepressants Puts New Jersey Women at Risk
... School of Medicine released a study revealing that women using tamoxifen to prevent a recurrence of breast cancer who also use certain selective serotonin reuptake inhibitors (SSRI), for example Prozac(R) (fluoxetine), Paxil(R) (paroxetine) and Zoloft(R) (sertraline), have up to twice the chance of ...... validation of neurogenesis as a target for the treatment of mood disorders like depression, in contrast to the traditional focus on affecting serotonin function for antidepressant drug development," said lead investigator Maurizio Fava, M.D., vice chair, department of psychiatry at Massachusetts ...
... has a unique chemical structure that differs from conventional and atypical antipsychotic agents. It possesses high affinities for dopamine D(2), serotonin 5-HT(7), 5-HT(2A), 5-HT(1A), and noradrenaline alpha(2C) receptors. Lurasidone exhibits little or no affinity for histamine H(1) or acetylcholine ...
... at how these drugs impact breast cancer recurrence rates when taken with tamoxifen. The antidepressants at issue are three widely used selective serotonin reuptake inhibitors (SSRIs), Prozac(R) (fluoxetine), Paxil(R) (paroxetine) and Zoloft(R) (sertraline), and are among a group of drugs known as CYP2D6 ...
Dainippon Sumitomo Pharma Announces Lurasidone Phase III Data in Patients With Schizophrenia
... Dainippon Sumitomo Pharma Co., Ltd., lurasidone is a novel compound with a unique receptor-binding profile including high affinity for dopamine D(2), serotonin 5-HT(2A), 5-HT(7), 5-HT(1A), and noradrenalin alpha(2c) receptors. Lurasidone has low affinity for histamine H(1), and cholinergic M(1) receptors. ...FDA Approves Vanda Pharmaceuticals' Fanapt(TM) for the Treatment of Schizophrenia
... and active control in patients with schizophrenia, as well as safety data from more than 3,000 patients. Fanapt(TM) is a mixed dopamine D2 / serotonin 5HT2A receptor antagonist, and belongs to the class of atypical antipsychotics. "The approval of Fanapt(TM) marks a new opportunity for many ...... Medications, both antidepressants and anti-anxiety drugs, also can help. Among antidepressants, the first choice often is a selective serotonin reuptake inhibitor (SSRI). This category includes fluoxetine (Prozac), paroxetine (Paxil), sertraline (Zoloft) and citalopram (Celexa). Other ...
... tested. At the highest dose tested (10 mg) we expect to have full occupancy of 5HT2A receptors while adding incremental amounts of D2 receptor and serotonin reuptake transporter (SERT) occupancy. This has been confirmed in an ongoing human Positron Emission Tomography (PET) study where we have ...
... behavioral therapy, physical activity, cardiac rehabilitation, antidepressant drugs or combinations of those treatments. -- Selective serotonin reuptake inhibitor (SSRI) treatment soon after a heart attack is considered safe, relatively inexpensive and may be effective for treating ...
MonoSol Rx Completes Thin Film Escitalopram Oxalate Pilot Product Development
... products, today announced the completion of pilot product development for its thin film formulation of escitalopram oxalate, a selective serotonin reuptake inhibitor. Escitalopram oxalate is indicated for depression and generalized anxiety disorders and is marketed under the brand name ...... averaging results from the screening PSGs. About APD125 Discovered by Arena, APD125 is a novel and oral selective inverse agonist of the 5-HT2A serotonin receptor. The vast majority of approved drugs for insomnia work by activating the GABA-A receptor complex in the brain, causing a general suppressive ...
... and total sleep time over 8 weeks in patients with co-morbid insomnia and major depressive disorder (MDD) who were administered a Selective serotonin Reuptake Inhibitor (SSRI) for depression. Ambien CR also improved sleep-related next-day functioning measures. This data was presented at the SLEEP ...
... by substance P and mediated by neurokinin (NK-1) receptors that are highly concentrated in the brain. The peripheral pathway is stimulated by serotonin and mediated by 5-HT3 receptors located primarily in the gut.(7) NK-1 receptor antagonists like casopitant block substance P from binding to ...
... for at least 6 months.(1,2) Several classes of drugs have demonstrated efficacy in the treatment of GAD. Treatment typically includes selective- serotonin reuptake inhibitors (SSRIs) or serotonin norepinephrine reuptake inhibitors (SNRIs); however, approximately 30 percent of patients do not achieve an ...
Study Demonstrates Lexapro(R) Significantly Improves Depression Symptoms in Adolescents
... of tricyclic antidepressants (TCAs) with Lexapro. SSRIs and SNRIs (including Lexapro) and other psychotropic drugs that interfere with serotonin reuptake may increase the risk of bleeding events. Concomitant use of aspirin, NSAIDs, warfarin and other anticoagulants may add to the risk. ...Other ContentspsoriaticpsoriaticpsoriaticpsychosispsychosispsychosisfibrosisfibrosisfibrosisfibrosisfibrosisfibrosisfibrosisfibrosisvenoptosispulsepulsepulsepulsepulsepulsepulsepulsepulsepubertypubertypubertypubertyOther TagsRageRageRageRageRageRageFell
(Date:12/4/2009)CORVALLIS, Ore. According to an analysis of statewide data taken from 1998-2001, women in Oregon who made less than $50,000 a year were more than three times likely to report they were discriminated
(Date:12/4/2009)The electroencephalogram (EEG) is widely used by physicians and scientists to study brain function and to diagnose neurological disorders. However, it has remained largely unknown whether the electrod
(Date:12/4/2009)A major discovery is challenging accepted thinking about amyloids the fibrous protein deposits associated with diseases such as Alzheimer,s and Parkinson,s and may open up a potential new area for t
Breaking Biology News(10 mins):Lower income women report more insurance-based discrimination during pregnancy, delivery 2How to read brain activity? 2New therapy targets for amyloid disease 2Climbing to new heights in the forest canopy 9503 1Climbing to new heights in the forest canopy 9503 2Sperm Cell Insights May Aid Stem Cell Research 53867 1Wrongful Death Lawsuit for Tyler R Hill Against Ambassadors Group docleaf et al Officially Settled 53862 1Wrongful Death Lawsuit for Tyler R Hill Against Ambassadors Group docleaf et al Officially Settled 53862 2Wrongful Death Lawsuit for Tyler R Hill Against Ambassadors Group docleaf et al Officially Settled 53862 3(Date:12/5/2009)Midbrook,s advanced Technology Center helps companies develop and test their cleaning processes. The technology available to the lab allows it to work in a variety of industries and solve problems for
(Date:12/5/2009)Wind Turbines are popping up in the most unusual places, and to do everything from growing mushrooms, making wine to keeping prisoners in jail! , (PRWEB) December 5, 2009 -- W
(Date:12/4/2009)NEW YORK, Dec. 4 Thousands of KPMG LLP employees came together in more than 90 offices nationwide today, to participate in a community service event which combines the audit, tax and advisory firm,s
(Date:12/4/2009)WASHINGTON, Dec. 4 The American Association of Homes and Services for the Aging (AAHSA) applauds the Senate for ensuring that the Community Living and Supportive Services (CLASS) provisions remain i
(Date:12/4/2009)MADISON HEIGHTS, Mich., Dec. 4 The Editorial Advisory and Securities Review Committee of BetterInvesting Magazine today announced Allergan, Inc. (NYSE: AGN ) as its February 2010 "Stock to Stud
Breaking Medicine News(10 mins):Health News:Midbrook Lab Testing Provides Results for Cleaning Process Develop and Verification 2Health News:Midbrook Lab Testing Provides Results for Cleaning Process Develop and Verification 3Health News:Distributor Announces New Applications for Wind Turbines 2Health News:Distributor Announces New Applications for Wind Turbines 3Health News:KPMG Employees Provide 'Holiday Bear Hugs' and Books in Firmwide Service Day for Children 2Health News:BetterInvesting Magazine Releases February Stock to Study and Undervalued Stock Choicesfor Investors' Informational and Educational Use 2[0] Midbrook Lab Testing Provides Results for Cleaning Process Develop and Verification[0] Distributor Announces New Applications for Wind Turbines [0] KPMG Employees Provide 'Holiday Bear Hugs' and Books in Firmwide Service Day for Children[0] Statement from AAHSA CEO Larry Minnix on the Failure of the Thune Amendment[0] BetterInvesting Magazine Releases February Stock to Study and Undervalued Stock Choicesfor Investors' Informational and Educational Use
DisenchantingschoolboyfretsRageimmediatelyUpfrontAlleviatingMaestroStaleFellCopycatCefotaximeDisplaceCheeks
Other Tagsunderground 2engine 2cats 2organic 2organic 3organic 4organic 5organic 6organic 7organic 8killing 2killing 3killing 4killing 5killing 6killing 7killing 8killing 9| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |